| Lipid Composition for LPGG-501 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-distearoyl-sn-glycero-3-phosphocholine | 6.15 | 7.79 | 60 |
| Cholesterol | 1.51 | 3.89 | 30 |
| 1,2-distearoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.52 | 0.65 | 5 |
| 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 1.82 | 0.65 | 5 |
| Total | 10 mg/vial | 12.98 umol | 100 |
| Lipid Composition for LPGG-502 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 6.14 | 7.81 | 60 |
| Cholesterol | 1.51 | 3.91 | 30 |
| 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.52 | 0.65 | 5 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 1.83 | 0.65 | 5 |
| Total | 10.00 mg/vial | 13.02 umol | 100 |
| Lipid Composition for LPSG-501 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-distearoyl-sn-glycero-3-phosphocholine | 6.15 | 7.78 | 60 |
| Cholesterol | 1.50 | 3.89 | 30 |
| 1,2-distearoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 0.53 | 0.65 | 5 |
| 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 1.82 | 0.65 | 5 |
| Total | 10 mg/vial | 12.97 umol | 100 |
| Lipid Composition for LPSG-502 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 6.14 | 7.81 | 60 |
| Cholesterol | 1.51 | 3.90 | 30 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 0.53 | 0.65 | 5 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 1.82 | 0.65 | 5 |
| Total | 10.00 mg/vial | 13.01 umol | 100 |
